TURNING POINT THERAPEUTICS I's ticker is TPTX and the CUSIP is 90041T108. A total of 173 filers reported holding TURNING POINT THERAPEUTICS I in Q4 2021. The put-call ratio across all filers is 4.75 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $1,583,000 | -41.1% | 58,967 | +3.3% | 0.00% | -50.0% |
| Q4 2021 | $2,688,000 | -28.2% | 57,072 | -1.4% | 0.00% | -33.3% |
| Q3 2021 | $3,742,000 | -14.3% | 57,867 | +3.2% | 0.00% | -25.0% |
| Q2 2021 | $4,368,000 | +15.8% | 56,067 | +40.5% | 0.00% | 0.0% |
| Q1 2021 | $3,773,000 | +54.8% | 39,896 | +99.5% | 0.00% | +33.3% |
| Q4 2020 | $2,437,000 | +108.5% | 20,000 | -35.7% | 0.00% | +200.0% |
| Q3 2019 | $1,169,000 | -46.9% | 31,098 | -42.5% | 0.00% | -66.7% |
| Q2 2019 | $2,201,000 | – | 54,070 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM BioImpact LLC | 308,686 | $13,786,000 | 8.42% |
| Cormorant Asset Management, LP | 3,056,797 | $136,517,000 | 6.34% |
| venBio Partners LLC | 160,333 | $7,160,000 | 6.10% |
| Burrage Capital Management LLC | 77,172 | $3,250,000 | 3.20% |
| Orbimed Advisors | 2,745,327 | $122,606,000 | 2.06% |
| Parkman Healthcare Partners LLC | 80,318 | $3,587,000 | 1.66% |
| SECTORAL ASSET MANAGEMENT INC | 117,800 | $5,261,000 | 1.01% |
| DAFNA Capital Management LLC | 46,908 | $2,095,000 | 0.87% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 35,000 | $1,542,000 | 0.70% |
| Nicholas Investment Partners, LP | 75,487 | $3,371,000 | 0.66% |